To drive true innovation in drug development, executives must not let excitement about the latest shiny object obscure ...
Merit Medical Systems (NASDAQ:MMSI) announced on Wednesday a definitive asset purchase agreement with Pentax to acquire the ...
"The idea is that any provider all over the world potentially participates in a clinical trial," Oracle' Seema Verma said.
RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and BioVie, Inc. (Nasdaq:BIVI) on the ...
2023 has brought major changes in the clinical research technology industry. As research sites face a backlog of clinical trials, they’re becoming more selective with which studies they take on.
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, has been awarded a three-year Small Business Innovation Research Grant (SBIR) Phase II for a project titled ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
Clinical trials are critical to the future of the healthcare system. While already a well-established activity, clinical trial protocols and compliance are always evolving. This continual ...
Regional Medical Center (RMC) is making strides toward becoming a leading healthcare provider in Alabama, according to ...
In the latest webinar of HealthLeaders' The Winning Edge series, a three-member panel will explore clinical care technology beyond artificial intelligence. In recent years, artificial intelligence has ...
A three-member panel of experts shares how to effectively use technology such as remote patient monitoring, wearables, and electronic health records. The latest webinar for HealthLeaders' The Winning ...
Medical schools across the country have been admonished to embrace the role of technology and consciously incorporate such in training doctors ready for the current sophisticated technologies in medic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results